| NCT06388083 | A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease | RECRUITING | PHASE2, PHASE3 | 2024-07-31 | 2028-01 | 2027-12 |
| NCT05949593 | Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy | RECRUITING | PHASE3 | 2023-07-27 | 2027-11-30 | 2027-08-31 |
| NCT05244304 | Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-03-28 | 2025-10 | 2025-08 |
| NCT04005807 | Safety and Tolerability of Escalating Doses of BPN-14967 in Healthy Adults | COMPLETED | PHASE1 | 2019-07-19 | 2019-12-20 | 2019-12-20 |